GlaxoSmithKline’s (GSK) triple therapy for chronic obstructive pulmonary disease (COPD) has been approved ... patients use three drugs in separate inhalers and the combination of corticosteroid ...
A further 500 were given the triple combination but in two inhalers. COPD is term used to describe a number of progressive ... “This is the first long-term study to look at the possibilities of triple ...
GlaxoSmithKline is set to launch its COPD triple therapy in the US - and must now ... of whom currently use three drugs in separate inhalers. The combination of an inhaled corticosteroid, long ...
"Given the added climate impact of metered-dose inhalers, health systems seeking ... The other single-inhaler on the market ...